8-K Announcements
6Material company update
May 8, 2026·SEC
Material company update
May 6, 2026·SEC
Material company update
Apr 17, 2026·SEC
Albemarle Corporation(ALB)Earnings, Financials & Key Ratios
ALB•NYSE
Price updated Jun 19, 2026
AboutAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.Show more
- Revenue$5.14B-4.4%
- EBITDA$754M+1773.8%
- Net Income-$511M+56.7%
- EPS (Diluted)-5.75+48.7%
- Gross Margin13.06%+1065.8%
- EBITDA Margin14.67%+1850.2%
- Operating Margin1.82%+115.4%
- Net Margin-9.93%+54.7%
- ROE-5.11%+57.0%
ALB Key Insights
Albemarle Corporation (ALB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Dividend Aristocrat: 32 years of consecutive increases
- ✓Strong 5Y sales CAGR of 10.4%
✗Weaknesses
- ✗Weak 3Y average ROE of 0.2%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ALB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ALB Price & Volume
Albemarle Corporation (ALB) stock price & volume — 10-year historical chart
Loading chart...
ALB Growth Metrics
Albemarle Corporation (ALB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.17%
5 Years10.45%
3 Years-11.1%
TTM7.87%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM79.58%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM69.34%
Return on Capital
10 Years6.95%
5 Years5.4%
3 Years-0.64%
Last Year0.64%
ALB Recent Earnings
Albemarle Corporation (ALB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$2.95+147.9%
$1.19
Rev
$1.4B+6.6%
$1.3B
Q1 2026
Feb 11, 2026Metric
Actual
Est
EPS
$0.53-26.8%
$0.42
Rev
$1.4B+6.0%
$1.3B
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.19+77.9%
$0.86
Rev
$1.3B+2.4%
$1.3B
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$0.11+113.3%
$0.83
Rev
$1.3B+4.6%
$1.3B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $2.95vs $1.19+147.9% | $1.4Bvs $1.3B+6.6% |
| Q1 2026 | Feb 11, 2026 | $0.53vs $0.42-26.8% | $1.4Bvs $1.3B+6.0% |
| Q4 2025 | Nov 5, 2025 | $0.19vs $0.86+77.9% | $1.3Bvs $1.3B+2.4% |
| Q3 2025 | Jul 30, 2025 | $0.11vs $0.83+113.3% | $1.3Bvs $1.3B+4.6% |
Based on last 12 quarters of dataView full earnings history →
ALB Peer Comparison
Albemarle Corporation (ALB) competitors in Catalysts and process chemicals — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SQM | 22.76B | 79.69 | 38.68 | 0.89% | 15.38% | 12.01% | 0.60 | |
 LAC | 975.73M | 4.37 | -8.57 | -8.28% | 0.10 | |||
 ECL | 76.01B | 269.12 | 36.97 | 2.16% | 12.91% | 21.96% | 0.96 | |
 ASH | 3.11B | 67.92 | -3.70 | -13.68% | -39.03% | -37.54% | 0.83 | |
 FMC | 1.44B | 11.55 | -0.65 | -18.34% | -72.93% | -82.27% | 2.00 | |
 HWKN | 3.37B | 161.45 | 41.29 | 11.21% | 7.52% | 15.96% | 0.49 | |
 IOSP | 2.04B | 82.73 | 17.72 | -3.65% | 6.38% | 8.64% | 0.07 | |
 TSLA | 1.5T | 400.49 | 370.82 | -2.93% | 3.96% | 4.75% | 0.10 |
Compare ALB vs Peers
Albemarle Corporation (ALB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ALB Income Statement
Albemarle Corporation (ALB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.07B | 3.37B | 3.59B | 3.13B | 3.33B | 7.32B | 9.62B | 5.38B | 5.14B | 5.49B |
Revenue Growth % | 14.75% | 9.86% | 6.35% | -12.83% | 6.36% | 119.96% | 31.38% | -44.08% | -4.37% | 7.87% |
Cost of Goods Sold | 1.95B | 2.15B | 2.33B | 2.13B | 2.32B | 4.23B | 8.42B | 5.32B | 4.47B | 4.48B |
COGS % of Revenue | 63.43% | 63.82% | 64.93% | 68.18% | 69.7% | 57.85% | 87.51% | 98.88% | 86.94% | - |
Gross Profit | 1.12B▲ 0% | 1.22B▲ 8.7% | 1.26B▲ 3.1% | 995.55M▼ 20.9% | 1.01B▲ 1.3% | 3.09B▲ 206.0% | 1.2B▼ 61.1% | 60.24M▼ 95.0% | 671.62M▲ 1014.9% | 1.02B▲ 0% |
Gross Margin % | 36.57% | 36.18% | 35.07% | 31.82% | 30.3% | 42.15% | 12.49% | 1.12% | 13.06% | 18.53% |
Gross Profit Growth % | 15.75% | 8.69% | 3.09% | -20.91% | 1.3% | 205.97% | -61.08% | -94.98% | 1014.92% | - |
Operating Expenses | 500.92M | 496.74M | 573.46M | 469.84M | 475.81M | 584.13M | 959.89M | 696.25M | 577.83M | 713.14M |
OpEx % of Revenue | 16.31% | 14.72% | 15.98% | 15.02% | 14.3% | 7.98% | 9.98% | 12.95% | 11.24% | - |
Selling, General & Admin | 422.29M | 426.69M | 515.17M | 410.63M | 421.79M | 512.14M | 874.16M | 609.52M | 526.43M | 545.79M |
SG&A % of Revenue | 13.75% | 12.64% | 14.35% | 13.12% | 12.67% | 7% | 9.09% | 11.33% | 10.24% | - |
Research & Development | 84.33M | 70.05M | 58.29M | 59.21M | 54.03M | 71.98M | 85.72M | 86.72M | 51.4M | 46.47M |
R&D % of Revenue | 2.75% | 2.08% | 1.62% | 1.89% | 1.62% | 0.98% | 0.89% | 1.61% | 1% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
Operating Income | 622.56M▲ 0% | 724.31M▲ 16.3% | 685.32M▼ 5.4% | 525.71M▼ 23.3% | 532.66M▲ 1.3% | 2.5B▲ 369.6% | 241.12M▼ 90.4% | -636.01M▼ 363.8% | 93.79M▲ 114.7% | 305.04M▲ 0% |
Operating Margin % | 20.27% | 21.46% | 19.09% | 16.8% | 16.01% | 34.17% | 2.51% | -11.83% | 1.82% | 5.55% |
Operating Income Growth % | 22.16% | 16.34% | -5.38% | -23.29% | 1.32% | 369.62% | -90.36% | -363.77% | 114.75% | - |
EBITDA | 819.49M | 925.01M | 898.81M | 757.7M | 786.66M | 2.8B | 671.07M | -45.07M | 754.37M | 801.97M |
EBITDA Margin % | 26.68% | 27.41% | 25.04% | 24.22% | 23.64% | 38.28% | 6.98% | -0.84% | 14.67% | 14.6% |
EBITDA Growth % | 11.37% | 12.88% | -2.83% | -15.7% | 3.82% | 256.23% | -76.05% | -106.72% | 1773.84% | 403.32% |
D&A (Non-Cash Add-back) | 196.93M | 200.7M | 213.48M | 231.98M | 254M | 300.84M | 429.94M | 590.94M | 660.58M | 496.92M |
EBIT | 622.56M | 724.31M | 685.32M | 525.71M | 532.66M | 2.5B | 241.12M | -636.01M | 93.79M | 305.04M |
Net Interest Income | -115.35M | -52.41M | -57.7M | -73.12M | -61.48M | -122.97M | -116.07M | -165.62M | -207.65M | -191.79M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 115.35M | 52.41M | 57.7M | 73.12M | 61.48M | 122.97M | 116.07M | 165.62M | 207.65M | 191.79M |
Other Income/Expense | -91.28M | 159.65M | 7.2M | -24.67M | -303.27M | 704.26M | 1.86B | -412.39M | -402.12M | -404.5M |
Pretax Income | 531.28M▲ 0% | 883.97M▲ 66.4% | 692.52M▼ 21.7% | 501.04M▼ 27.6% | 229.39M▼ 54.2% | 3.21B▲ 1297.5% | 2.1B▼ 34.5% | -1.05B▼ 149.9% | -308.33M▲ 70.6% | -99.45M▲ 0% |
Pretax Margin % | 17.29% | 26.19% | 19.29% | 16.01% | 6.89% | 43.79% | 21.84% | -19.5% | -6% | -1.81% |
Income Tax | 431.82M | 144.83M | 88.16M | 54.42M | 29.45M | 390.59M | 430.28M | 87.08M | 156.88M | 182.37M |
Effective Tax Rate % | 81.28% | 16.38% | 12.73% | 10.86% | 12.84% | 12.18% | 20.48% | -8.31% | -50.88% | -183.37% |
Net Income | 54.85M▲ 0% | 693.56M▲ 1164.5% | 533.23M▼ 23.1% | 375.76M▼ 29.5% | 123.67M▼ 67.1% | 2.69B▲ 2075.0% | 1.57B▼ 41.5% | -1.18B▼ 175.0% | -510.63M▲ 56.7% | -232.88M▲ 0% |
Net Margin % | 1.79% | 20.55% | 14.86% | 12.01% | 3.72% | 36.75% | 16.36% | -21.93% | -9.93% | -4.24% |
Net Income Growth % | -91.48% | 1164.47% | -23.12% | -29.53% | -67.09% | 2074.96% | -41.5% | -174.96% | 56.71% | 79.58% |
Net Income (Continuing) | 99.47M | 739.14M | 604.36M | 446.62M | 199.94M | 2.82B | 1.67B | -1.14B | -465.21M | -281.82M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 143.15M | 173.79M | 161.33M | 200.37M | 180.34M | 208.22M | 252.92M | 238.17M | 248.1M | 257.94M |
EPS (Diluted) | 0.49▲ 0% | 6.34▲ 1193.9% | 5.02▼ 20.8% | 3.52▼ 29.9% | 1.06▼ 69.9% | 22.84▲ 2054.7% | 13.36▼ 41.5% | -11.20▼ 183.8% | -5.75▲ 48.7% | -1.96▲ 0% |
EPS Growth % | -91.37% | 1193.88% | -20.82% | -29.88% | -69.89% | 2054.72% | -41.51% | -183.83% | 48.66% | 69.34% |
EPS (Basic) | 0.49 | 6.40 | 5.03 | 3.53 | 1.07 | 22.97 | 13.41 | -11.20 | -5.75 | - |
Diluted Shares Outstanding | 112.38M | 109.46M | 106.32M | 106.81M | 116.54M | 117.79M | 117.77M | 117.52M | 117.7M | 118.61M |
Basic Shares Outstanding | 110.91M | 108.43M | 105.95M | 106.4M | 115.84M | 117.12M | 117.32M | 117.52M | 117.7M | 117.85M |
Dividend Payout Ratio | 256.26% | 20.85% | 28.54% | 43.06% | 143.81% | 6.86% | 11.9% | - | - | - |
ALB Balance Sheet
Albemarle Corporation (ALB) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2.48B | 2B | 2.23B | 2.21B | 1.99B | 5.19B | 5.22B | 3.84B | 4.01B | 3.26B |
Cash & Short-Term Investments | 1.14B | 555.32M | 613.11M | 746.72M | 439.27M | 1.5B | 889.9M | 1.19B | 1.62B | 1.09B |
Cash Only | 1.14B | 555.32M | 613.11M | 746.72M | 439.27M | 1.5B | 889.9M | 1.19B | 1.62B | 1.09B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 619.39M | 697.89M | 752.45M | 530.84M | 700.06M | 1.45B | 1.84B | 1.07B | 764.77M | 659.48M |
Days Sales Outstanding | 73.59 | 75.48 | 76.51 | 61.92 | 76.78 | 72.23 | 69.65 | 72.33 | 54.28 | 52.23 |
Inventory | 592.78M | 700.54M | 768.98M | 750.24M | 798.62M | 2.08B | 2.16B | 1.5B | 1.18B | 1.35B |
Days Inventory Outstanding | 111.04 | 118.71 | 120.43 | 128.36 | 125.67 | 178.95 | 93.73 | 103.14 | 96.27 | 116.19 |
Other Current Assets | 41.74M | 1.5M | 6.93M | 120.85M | 5.8M | 6.72M | 6.59M | 4.75M | 374.19M | 162.93M |
Total Non-Current Assets | 5.27B | 5.58B | 7.64B | 8.24B | 8.98B | 10.27B | 13.05B | 12.77B | 12.37B | 11.88B |
Property, Plant & Equipment | 2.49B | 3.02B | 5.04B | 5.35B | 6.06B | 7.09B | 9.63B | 9.45B | 8.73B | 8.53B |
Fixed Asset Turnover | 1.23x | 1.12x | 0.71x | 0.58x | 0.55x | 1.03x | 1.00x | 0.57x | 0.59x | 0.62x |
Goodwill | 1.61B | 1.57B | 1.58B | 1.67B | 1.6B | 1.62B | 1.63B | 1.58B | 1.5B | 1.49B |
Intangible Assets | 421.5M | 386.14M | 354.62M | 349.11M | 308.95M | 287.87M | 261.86M | 230.75M | 214.23M | 207.62M |
Long-Term Investments | 534.06M | 528.72M | 579.81M | 656.24M | 912.01M | 1.15B | 1.37B | 1.12B | 900.93M | 3.73B |
Other Non-Current Assets | 188.87M | 63.11M | 63.92M | 198.95M | 78.7M | 75.95M | 137.25M | 332.26M | 1B | 636.57M |
Total Assets | 7.75B▲ 0% | 7.58B▼ 2.2% | 9.86B▲ 30.1% | 10.45B▲ 6.0% | 10.97B▲ 5.0% | 15.46B▲ 40.8% | 18.27B▲ 18.2% | 16.61B▼ 9.1% | 16.37B▼ 1.4% | 15.14B▲ 0% |
Asset Turnover | 0.40x | 0.45x | 0.36x | 0.30x | 0.30x | 0.47x | 0.53x | 0.32x | 0.31x | 0.33x |
Asset Growth % | -5.03% | -2.18% | 30.06% | 5.98% | 5.01% | 40.85% | 18.21% | -9.09% | -1.42% | -20.08% |
Total Current Liabilities | 1.2B | 1.18B | 1.41B | 1.8B | 1.87B | 2.74B | 3.56B | 1.97B | 1.8B | 1.58B |
Accounts Payable | 418.54M | 522.52M | 574.14M | 483.22M | 647.99M | 2.05B | 2.09B | 943.89M | 913.53M | 933.78M |
Days Payables Outstanding | 78.4 | 88.55 | 89.92 | 82.68 | 101.97 | 176.88 | 90.56 | 64.79 | 74.58 | 73.57 |
Short-Term Debt | 422.01M | 307.29M | 187.34M | 804.68M | 389.92M | 2.13M | 625.76M | 398.02M | 74.08M | 74.63M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.12M | 93.09M | 93.09M |
Other Current Liabilities | 95.33M | 77.81M | 58.89M | 102.71M | 100.72M | 145.88M | 168.36M | 157.15M | 331.96M | 114.59M |
Current Ratio | 2.06x | 1.69x | 1.58x | 1.22x | 1.06x | 1.89x | 1.47x | 1.95x | 2.23x | 2.07x |
Quick Ratio | 1.57x | 1.10x | 1.03x | 0.81x | 0.64x | 1.13x | 0.86x | 1.19x | 1.57x | 1.21x |
Cash Conversion Cycle | 106.23 | 105.64 | 107.03 | 107.61 | 100.48 | 74.3 | 72.83 | 110.67 | 75.97 | 94.85 |
Total Non-Current Liabilities | 2.73B | 2.64B | 4.36B | 4.18B | 3.29B | 4.52B | 5.05B | 4.44B | 4.79B | 3.46B |
Long-Term Debt | 1.42B | 1.4B | 2.86B | 2.77B | 2B | 3.21B | 3.54B | 3.12B | 3.12B | 1.81B |
Capital Lease Obligations | 0 | 0 | 114.69M | 116.77M | 127M | 99.27M | 113.68M | 99.51M | 103.11M | 306.26M |
Deferred Tax Liabilities | 370.39M | 382.98M | 397.86M | 394.85M | 353.28M | 480.77M | 558.43M | 358.03M | 368.27M | 1.51B |
Other Non-Current Liabilities | 946.4M | 858.5M | 982.82M | 901.5M | 809.58M | 729.65M | 753.95M | 789.78M | 863.33M | 1.28B |
Total Liabilities | 3.93B | 3.82B | 5.77B | 5.98B | 5.17B | 7.27B | 8.61B | 6.41B | 6.59B | 5.03B |
Total Debt | 1.84B | 1.71B | 3.19B | 3.69B | 2.52B | 3.32B | 4.28B | 3.62B | 3.3B | 1.88B |
Net Debt | 700.07M | 1.15B | 2.57B | 2.94B | 2.08B | 1.82B | 3.39B | 2.42B | 1.68B | 792.02M |
Debt / Equity | 0.48x | 0.45x | 0.78x | 0.83x | 0.43x | 0.40x | 0.44x | 0.35x | 0.34x | 0.19x |
Debt / EBITDA | 2.24x | 1.84x | 3.55x | 4.87x | 3.20x | 1.18x | 6.38x | - | 4.37x | 2.35x |
Net Debt / EBITDA | 0.85x | 1.24x | 2.86x | 3.88x | 2.65x | 0.65x | 5.05x | - | 2.23x | 0.99x |
Interest Coverage | 5.40x | 13.82x | 11.88x | 7.19x | 8.66x | 20.34x | 2.08x | -3.84x | 0.45x | 1.59x |
Total Equity | 3.82B▲ 0% | 3.76B▼ 1.5% | 4.09B▲ 8.9% | 4.47B▲ 9.2% | 5.81B▲ 29.9% | 8.19B▲ 41.1% | 9.67B▲ 18.0% | 10.2B▲ 5.5% | 9.78B▼ 4.1% | 10.11B▲ 0% |
Equity Growth % | -3.17% | -1.53% | 8.9% | 9.16% | 29.92% | 41.09% | 18% | 5.53% | -4.1% | -16.4% |
Book Value per Share | 33.97 | 34.34 | 38.50 | 41.84 | 49.82 | 69.54 | 82.07 | 86.79 | 83.10 | 85.22 |
Total Shareholders' Equity | 3.67B | 3.59B | 3.93B | 4.27B | 5.63B | 7.98B | 9.41B | 9.96B | 9.53B | 9.85B |
Common Stock | 1.1M | 1.06M | 1.06M | 1.07M | 1.17M | 1.17M | 1.17M | 1.18M | 1.18M | 1.18M |
Retained Earnings | 2.04B | 2.57B | 2.94B | 3.16B | 3.1B | 5.6B | 6.99B | 5.48B | 4.61B | 4.84B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -225.67M | -350.68M | -395.74M | -326.13M | -392.45M | -560.66M | -528.53M | -742.06M | -334.81M | -259.11M |
Minority Interest | 143.15M | 173.79M | 161.33M | 200.37M | 180.34M | 208.22M | 252.92M | 238.17M | 248.1M | 257.94M |
ALB Cash Flow Statement
Albemarle Corporation (ALB) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 303.98M | 546.16M | 719.37M | 798.91M | 344.26M | 1.91B | 1.33B | 687.88M | 1.28B | 1.08B |
Operating CF Margin % | 9.9% | 16.18% | 20.04% | 25.53% | 10.34% | 26.06% | 13.79% | 12.79% | 24.93% | - |
Operating CF Growth % | -58.55% | 79.67% | 31.71% | 11.06% | -56.91% | 454.19% | -30.47% | -48.15% | 86.41% | 57456.83% |
Net Income | 99.47M | 739.14M | 604.36M | 446.62M | 199.94M | 2.82B | 1.67B | -1.14B | -465.21M | -232.88M |
Depreciation & Amortization | 196.93M | 200.7M | 213.48M | 231.98M | 254M | 300.84M | 429.94M | 588.64M | 658.68M | 654.73M |
Stock-Based Compensation | 19.4M | 15.23M | 19.68M | 22.84M | 20.12M | 30.47M | 36.55M | 32.14M | 40.27M | 41.19M |
Deferred Taxes | -41.94M | 49.16M | 14.39M | -1.98M | -38.5M | 93.34M | 100.88M | -230.41M | 81.17M | 85.83M |
Other Non-Cash Items | 422.38M | -306.1M | -18.2M | 185.99M | -203.03M | 82.77M | 95.93M | 696.11M | 272.98M | -85.03M |
Working Capital Changes | -392.26M | -151.97M | -114.34M | -86.53M | 111.72M | -1.41B | -1.01B | 736.87M | 694.38M | 571.94M |
Change in Receivables | -74.55M | -97.45M | -18.22M | 100.12M | -49.3M | -786.12M | -350.65M | 555.22M | 47.31M | 0 |
Change in Inventory | -101.55M | -124.07M | -46.3M | 51.98M | -127.4M | -1.61B | -353.56M | 1.06B | 212.35M | 0 |
Change in Payables | 53.42M | 73.73M | -12.23M | -31.52M | 143.94M | 1.29B | -283.41M | -862.24M | 128.15M | 0 |
Cash from Investing | -357.8M | -303.69M | -1.66B | -863.57M | -666.59M | -1.42B | -2.56B | -1.58B | -146.01M | 574.26M |
Capital Expenditures | -317.7M | -699.99M | -851.8M | -850.48M | -953.67M | -1.26B | -2.15B | -1.68B | -589.8M | -505.85M |
CapEx % of Revenue | 10.34% | 20.74% | 23.73% | 27.18% | 28.66% | 17.24% | 22.4% | 31.25% | 11.47% | 9.21% |
Acquisitions | -39.83M | 402.17M | -820M | -11.57M | 283.3M | -162.94M | -427.43M | -270K | -239K | -238K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 10.36M | 0 | 6.49M | 706K | 0 | 29.1M | 32.81M | 1.01B |
Cash from Financing | -1.09B | -786.53M | 1.04B | 177.26M | 50.21M | 611.89M | 623.91M | 1.24B | -834.19M | -2.13B |
Debt Issued (Net) | -612.46M | -113.57M | 1.3B | 339.8M | -1.11B | 867.55M | 944.2M | -631.83M | -454.67M | -1.72B |
Equity Issued (Net) | -250M | -500M | 0 | 0 | 1.45B | 0 | 0 | 2.24B | 0 | 4.98M |
Dividends Paid | -140.56M | -144.6M | -152.2M | -161.82M | -177.85M | -184.43M | -187.19M | -311.28M | -357.28M | -357.34M |
Share Repurchases | -250M | -500M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.94M |
Other Financing | -83.85M | -28.36M | -101.34M | -719K | -112.99M | -71.24M | -133.1M | -51.91M | -22.24M | -53.12M |
Net Change in Cash | -1.13B▲ 0% | -581.98M▲ 48.6% | 57.79M▲ 109.9% | 133.61M▲ 131.2% | -307.45M▼ 330.1% | 1.06B▲ 444.7% | -609.24M▼ 157.5% | 302.33M▲ 149.6% | 425.77M▲ 40.8% | -428.7M▲ 0% |
Free Cash Flow | -13.72M▲ 0% | -153.83M▼ 1020.9% | -132.42M▲ 13.9% | -51.56M▲ 61.1% | -609.41M▼ 1081.9% | 646.2M▲ 206.0% | -827.96M▼ 228.1% | -992.65M▼ 19.9% | 692.47M▲ 169.8% | 577.27M▲ 0% |
FCF Margin % | -0.45% | -4.56% | -3.69% | -1.65% | -18.31% | 8.83% | -8.61% | -18.46% | 13.46% | 10.51% |
FCF Growth % | -102.56% | -1020.85% | 13.91% | 61.06% | -1081.87% | 206.04% | -228.13% | -19.89% | 169.76% | 469.12% |
FCF per Share | -0.12 | -1.41 | -1.25 | -0.48 | -5.23 | 5.49 | -7.03 | -8.45 | 5.88 | 4.87 |
FCF Conversion (FCF/Net Income) | 5.54x | 0.79x | 1.35x | 2.13x | 2.78x | 0.71x | 0.84x | -0.58x | -2.51x | -2.48x |
Interest Paid | 0 | 0 | 0 | 0 | 27.73M | 92.09M | 101.98M | 150.69M | 180.71M | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 130.84M | 248.14M | 319.39M | 262.85M | 152.48M | 0 |
ALB Key Ratios
Albemarle Corporation (ALB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 1.41% | 18.31% | 13.58% | 8.78% | 2.41% | 38.44% | 17.62% | -11.87% | -5.11% | -2.29% |
Return on Invested Capital (ROIC) | 10.91% | 11.53% | 8.88% | 5.6% | 5.22% | 20.97% | 1.57% | -3.72% | 0.58% | 1.95% |
Gross Margin | 36.57% | 36.18% | 35.07% | 31.82% | 30.3% | 42.15% | 12.49% | 1.12% | 13.06% | 18.53% |
Net Margin | 1.79% | 20.55% | 14.86% | 12.01% | 3.72% | 36.75% | 16.36% | -21.93% | -9.93% | -4.24% |
Debt / Equity | 0.48x | 0.45x | 0.78x | 0.83x | 0.43x | 0.40x | 0.44x | 0.35x | 0.34x | 0.19x |
Interest Coverage | 5.40x | 13.82x | 11.88x | 7.19x | 8.66x | 20.34x | 2.08x | -3.84x | 0.45x | 1.59x |
FCF Conversion | 5.54x | 0.79x | 1.35x | 2.13x | 2.78x | 0.71x | 0.84x | -0.58x | -2.51x | -2.48x |
Revenue Growth | 14.75% | 9.86% | 6.35% | -12.83% | 6.36% | 119.96% | 31.38% | -44.08% | -4.37% | 7.87% |
Related:ALB Dividend History·ALB Revenue History·ALB Price History·ALB P/E History·ALB Financial Ratios·ALB Institutional Holders
ALB SEC Filings & Documents
Albemarle Corporation (ALB) SEC filings — annual & quarterly reports (10-K, 10-Q)
ALB Frequently Asked Questions
Albemarle Corporation (ALB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Albemarle Corporation (ALB) reported $5.49B in revenue for fiscal year 2025. This represents a 543% increase from $854.5M in 1996.
Albemarle Corporation (ALB) saw revenue decline by 4.4% over the past year.
Albemarle Corporation (ALB) reported a net loss of $232.9M for fiscal year 2025.
Dividend & Returns
Yes, Albemarle Corporation (ALB) pays a dividend with a yield of 1.01%. This makes it attractive for income-focused investors.
Albemarle Corporation (ALB) has a return on equity (ROE) of -5.1%. Negative ROE indicates the company is unprofitable.
Albemarle Corporation (ALB) generated $577.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.